Skip to main content
Egyptian Liver Journal

Table 5 Correlation between Pre-treatment HOMA -IR with demographic and laboratory data in both Groups of patients

From: Assessment of serum Resistin in detecting Insulin Resistance and their impact on response to direct acting antiviral in chronic viral hepatitis C patients

Correlations

 

HOMA Pre

Naive

Relapser

r

P-value

r

P-value

Age(years)

-0.086

0.717

0.175

0.460

BMI(kg/m2

-0.097

0.683

0.265

0.258

ALT (IU/L)

0.187

0.431

0.468

0.307

AST(IU/L)

0.004

0.987

-0.416

0.068

Alb(g/dL)

0.095

0.691

-0.227

0.335

Bil(mg/dL)

0.191

0.420

0.107

0.653

Hb(g/dL)

-0.091

0.702

0.130

0.585

TLC(×103/μL)

0.244

0.300

0.090

0.705

Plat(×103/μL)

-0.093

0.696

-0.013

0.957

INR

0.361

0.118

-0.270

0.251

FBS Pre(mg/dL)

0.667

0.001*

0.507

0.075

Fasting Insulin Pre(μU/ml)

0.856

<0.001*

0.794

<0.001*

Resistin Pre(ng/L)

0.745

<0.001*

0.769

<0.001*

PCR(IU/mL)

0.014

0.953

-0.061

0.800

AFP(ng/mL)

0.162

0.494

0.070

0.769

FIB4

-0.115

0.629

-0.134

0.573

  1. This table shows a significant positive correlation between Pre-treatment HOMA-IR and Fasting Insulin & Resistin among Naïve & Relapser Patients and FBS among naïve patients with insignificant correlation with all other parameters
Back to article page